体力活动与肥胖对肝脏相关死亡风险的对比:两项前瞻性全国队列研究
该研究基于两项美国全国性前瞻性队列(77,238名女性和48,026名男性),从1986年至2012年每两年评估体力活动、肥胖及饮食等,分析肝脏相关死亡风险。结果显示肥胖和体力活动不足均为独立预测因素,较高体力活动可抵消肥胖带来的超额风险。每周平均步速步行超过3小时可预防25%的肝脏相关死亡。
要点
- 成年期BMI升高和早期体重增加与肝脏相关死亡风险单调增加相关(趋势P<0.0001)。
- 体力活动增加与肝脏相关死亡风险逐步降低相关(趋势P=0.0003)。
- 与瘦且活跃者相比,肥胖且活跃者风险无显著增加(aHR 1.04),而瘦且久坐和肥胖且久坐者风险显著增加。
核心结论
- 在两项前瞻性全国队列中,过度肥胖和体力活动减少均是肝脏相关死亡的显著预测因素。
- 达到较高体力活动水平可抵消肥胖相关的超额肝脏风险。
研究设计与样本
- 前瞻性队列研究,纳入77,238名女性和48,026名男性,从1986年至2012年每两年进行经验证的体力活动、肥胖、饮食、酒精使用和临床合并症评估。
- 使用Cox比例风险回归模型计算多变量调整的风险比(aHR)和95%CI,随访共1,856,226人年。
主要发现
- 共记录295例肝脏相关死亡(108例HCC,187例肝硬化)。
- 成年期BMI升高与肝脏相关死亡风险单调增加相关(趋势P<0.0001),早期成年期体重增加亦相关(趋势P<0.0001)。
- 体力活动增加与肝脏相关死亡风险逐步降低相关(趋势P=0.0003);按五分位递增的aHR分别为1.0、0.70(95%CI 0.51-0.96)、0.59(95%CI 0.42-0.84)、0.52(95%CI 0.36-0.74)和0.46(95%CI 0.31-0.66)。
- 与瘦且活跃者(BMI<25;≥18 MET-小时/周)相比,肥胖且活跃、瘦且久坐、肥胖且久坐者的aHR分别为1.04(95%CI 0.73-1.37)、2.08(95%CI 1.21-3.33)和3.40(95%CI 2.06-5.56)。
- HCC特异性和肝硬化特异性死亡率结果相似。
关键数值与推荐
- 每周平均步速步行超过3小时可预防25%的肝脏相关死亡(95%CI 0.12-0.38)。
- 瘦且活跃定义为BMI<25且每周≥18 MET-小时。
临床怎么用
- 临床评估肝脏相关死亡风险时应同时关注肥胖和体力活动水平。
- 鼓励肥胖患者达到每周平均步速步行超过3小时或等效体力活动,以降低肝脏相关死亡风险。
局限性
- 观察性研究设计不能完全排除残余混杂。
- 体力活动和肥胖通过自我报告评估,可能存在测量误差。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Obesity in adulthood has been associated with increased risk of liver-related mortality. Whether higher levels of physical activity counteract the excess risk conferred by obesity remains unknown. We simultaneously evaluated the long-term impact of physical activity and adiposity on liver-related mortality, within 2 nationwide populations. METHODS: We conducted a prospective cohort study of 77,238 women and 48,026 men, with detailed, validated assessments of weekly physical activity (metabolic equivalent task [MET]-hours]), adiposity (body mass index [BMI], waist circumference), and diet, alcohol use and clinical comorbidities, biennially from 1986 through 2012. Using Cox proportional hazards regression models, we calculated multivariable-adjusted hazard ratios (aHRs) and 95% CIs for liver-related mortality, including death from hepatocellular carcinoma (HCC) and other complications of cirrhosis. RESULTS: Over 1,856,226 person-years, we recorded 295 liver-related deaths (108 HCC; 187 cirrhosis). Risk of liver-related mortality increased monotonically with higher BMI during adulthood (ptrend<0.0001) and with weight gain during early adulthood (ptrend <0.0001). The risk of liver-related mortality also declined progressively, with increasing physical activity (ptrend = 0.0003); the aHRs across increasing physical activity quintiles were: 1.0, 0.70 (95% CI 0.51-0.96), 0.59 (95% CI 0.42-0.84), 0.52 (95% CI 0.36-0.74) and 0.46 (95% CI 0.31-0.66). Compared to lean-active adults (BMI <25; ≥18 MET-hours/week), the aHRs for obese-active, lean-sedentary, and obese-sedentary adults were: 1.04 (95% CI 0.73-1.37), 2.08 (95% CI 1.21-3.33) and 3.40 (95% CI 2.06-5.56), respectively. Findings were similar for HCC-specific and cirrhosis-specific mortality. Overall, engaging in average-pace walking for >3 hours/week could have prevented 25% of liver-related deaths (95% CI 0.12-0.38). CONCLUSIONS: In 2 prospective, nationwide cohorts, both excess adiposity and reduced physical activity were significant predictors of liver-related mortality. Achieving higher physical activity levels counteracted the excess liver-related risks associated with obesity. LAY SUMMARY: This is the first large, prospective cohort study to simultaneously evaluate the impact of obesity and physical activity on the long-term risk of liver-related mortality in 2 nationwide populations of American men and women. The study demonstrated that obesity predicted significantly increased risk of liver-related mortality, while physical activity predicted significantly lower risk of liver-related mortality. Importantly, the excess risk of liver-related mortality observed with obesity was no longer statistically significant among adults who engaged in the equivalent of average-pace walking for 3 hours or more, per week.
引用
- Simon TG, Kim MN, Luo X, et al. Physical activity compared to adiposity and risk of liver-related mortality: Results from two prospective, nationwide cohorts. J Hepatol. 2020. PMID: 31954204. doi:10.1016/j.jhep.2019.12.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。